Literature DB >> 22282621

Widespread Emergence of Multidrug Resistant Pseudomonas aeruginosa Isolated from CSF Samples.

S Nagaveni, H Rajeshwari, Ajay Kumar Oli, S A Patil, R Kelmani Chandrakanth.   

Abstract

Bacterial infections of the central nervous system, especially acute infections such as bacterial meningitis require immediate, invariably empiric antibiotic therapy due to the widespread emergence of resistance among bacterial species. Nosocomial infections by Pseudomonas aeruginosa have been described with an increasing trend towards multidrug resistance. P. aeruginosa isolates n = 53 (66%) isolated from the cerebrospinal fluid (CSF) were used for this study. Antibiotic resistance in 53 P. aeruginosa clinical isolates from 80 CSF samples were evaluated. Of these, n = 42 (80%) of the isolates showed multidrug resistance to more than eight antibiotics and n = 17 (32%) isolates were found to be imipenem resistant P. aeruginosa (IMPR-Pa). Genotypical examination by ERIC based PCR revealed minor genetic variations. Polymicrobial infections are common in the CSF samples. However, high prevalence of P. aeruginosa as an opportunistic pathogen has been developing with increased resistance to antimicrobial agents and thus becoming a significant threat.

Entities:  

Keywords:  Antibiotics; CSF; MIC; Nosocomial infections; Prevalence; Pseudomonas aeruginosa

Year:  2011        PMID: 22282621      PMCID: PMC3209859          DOI: 10.1007/s12088-011-0062-0

Source DB:  PubMed          Journal:  Indian J Microbiol        ISSN: 0046-8991            Impact factor:   2.461


  19 in total

1.  Of Pseudomonas, porins, pumps and carbapenems.

Authors:  D M Livermore
Journal:  J Antimicrob Chemother       Date:  2001-03       Impact factor: 5.790

Review 2.  Aminoglycoside resistance in Pseudomonas aeruginosa.

Authors:  Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

Review 3.  Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America.

Authors:  George H Talbot; John Bradley; John E Edwards; David Gilbert; Michael Scheld; John G Bartlett
Journal:  Clin Infect Dis       Date:  2005-01-25       Impact factor: 9.079

4.  High prevalence of carbapenem resistant Pseudomonas aeruginosa at a tertiary care centre of north India. Are we under-reporting?

Authors:  Bijayini Behera; Anupam Das; Purva Mathur; Arti Kapil
Journal:  Indian J Med Res       Date:  2008-09       Impact factor: 2.375

5.  Carbapenem derivatives as potential inhibitors of various beta-lactamases, including class B metallo-beta-lactamases.

Authors:  R Nagano; Y Adachi; H Imamura; K Yamada; T Hashizume; H Morishima
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

6.  Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents.

Authors:  Y Carmeli; N Troillet; G M Eliopoulos; M H Samore
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

7.  Application of different genotyping methods for Pseudomonas aeruginosa in a setting of endemicity in an intensive care unit.

Authors:  H Speijer; P H Savelkoul; M J Bonten; E E Stobberingh; J H Tjhie
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

Review 8.  Metallo-beta-lactamases: a class apart.

Authors:  K Bush
Journal:  Clin Infect Dis       Date:  1998-08       Impact factor: 9.079

9.  Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes.

Authors:  J Versalovic; T Koeuth; J R Lupski
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

10.  Nosocomial enterococcal blood stream infections in the SCOPE Program: antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. SCOPE Hospital Study Group.

Authors:  R N Jones; S A Marshall; M A Pfaller; W W Wilke; R J Hollis; M E Erwin; M B Edmond; R P Wenzel
Journal:  Diagn Microbiol Infect Dis       Date:  1997-10       Impact factor: 2.803

View more
  7 in total

1.  Detection of Metallo Beta-Lactamase (MBL) Producing Pseudomonas aeruginosa in a Tertiary Care Hospital, Ghanpur, Medchal, India.

Authors:  A Radhika; Jyothi Tadi Lakshmi; Kaliappan Ariyanachi; Varatharajan Sakthivadivel
Journal:  Maedica (Bucur)       Date:  2022-03

Review 2.  Antibiotic regimens for treatment of infections due to multidrug-resistant Gram-negative pathogens: An evidence-based literature review.

Authors:  Mandana Izadpanah; Hossein Khalili
Journal:  J Res Pharm Pract       Date:  2015 Jul-Sep

3.  Draft Genome Sequence of Multidrug-Resistant Pseudomonas aeruginosa Strain VRFPA02, Isolated from a Septicemic Patient in India.

Authors:  Jambulingam Malathi; Nandagopal Murugan; Vetrivel Umashankar; Radhakrishnan Bagyalakshmi; Hajib Narahari Rao Madhavan
Journal:  Genome Announc       Date:  2013-07-05

4.  Retrospective analysis of multiplex polymerase chain reaction-based molecular diagnostics (SES) in 70 patients with suspected central nervous system infections: A single-center study.

Authors:  Rama Krishnan Tiruppur Chinnappan Ramalingam; Dipanjan Chakraborty
Journal:  Ann Indian Acad Neurol       Date:  2016 Oct-Dec       Impact factor: 1.383

5.  Green synthesis of AgNPs@PPE and its Pseudomonas aeruginosa biofilm formation activity compared to pomegranate peel extract.

Authors:  Reza Habibipour; Leila Moradi-Haghgou; Abbas Farmany
Journal:  Int J Nanomedicine       Date:  2019-08-28

6.  Dissemination of Pseudomonas aeruginosa producing bla IMP-1 and bla VIM-1 in Qazvin and Alborz educational hospitals, Iran.

Authors:  Amir Peymani; Taghi Naserpour Farivar; Mahdi Mohammadi Ghanbarlou; Reza Najafipour
Journal:  Iran J Microbiol       Date:  2015-12

7.  Phenotypic and genetic properties of susceptible and multidrug-resistant Pseudomonas aeruginosa isolates in Southern Serbia.

Authors:  Marko Milojković; Željka Nenadović; Slaviša Stanković; Dragana D Božić; Nataša Stanković Nedeljković; Ivana Ćirković; Marija Petrović; Ivica Dimkić
Journal:  Arh Hig Rada Toksikol       Date:  2020-10-06       Impact factor: 2.078

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.